TMCnet News

External Defibrillators Market Size Worth $6.5 Billion By 2030: Grand View Research, Inc.
[January 11, 2022]

External Defibrillators Market Size Worth $6.5 Billion By 2030: Grand View Research, Inc.

SAN FRANCISCO, Jan. 11, 2022 /PRNewswire/ -- The global external defibrillators market size is anticipated to reach USD 6.5 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a notable CAGR of 9.3% from 2022 to 2030. The key factors driving the market growth include rising technological advancements, initiatives for promoting public access AEDs, and the incidence of sudden cardiac arrest. The COVID-19 pandemic increased awareness about defibrillation training and the use of external defibrillators in case of an adverse cardiac event, thus increasing demand for defibrillators. The pandemic also resulted in logistical bottlenecks and operational challenges.


Key Insights & Findings from the report:

  • The market was valued at USD 2.9 billion in 2021 and is expected to expand at a CAGR of 9.3% during the forecast period
  • The manual external defibrillators segment held the largest revenue share of the market in 2021
  • The end-use segment, on the other hand, was dominated by hospitals as these register the highest patient volume thus requiring defibrillators as part of their cardiology units
  • North America dominated the market in 2021 due to the presence of key players and growing strategic initiatives deployed by these companies
  • For instance, in April 2019 Stryker launched LIFEPAK CR2 AED in the U.S., expanding its lineup of defibrillation solutions. The product connects to an AED program manager, LIFELINKcentral, to help an organization's AED manager to monitor and manage device readiness issues remotely. When connected to Wi-Fi, the device also provides near real-time email alerts
  • Obesity and hypertension are also risk factors for SCA. Obesity continues to be a significant public health crisis. According to a study published online in Pediatrics, obesity rates among children significantly increased during the first few months of the COVID-19 pandemic
  • Around 80.0% of sudden cardiac deaths are linked to coronary heart disease. It is the most common type of heart disease, and as per CDC, approximately 18.2 million adults aged 20 and older suffer from this disease. Thus, AEDs are important because they increase the chance of survival. They can restore a normal heart rhythm in sudden cardiac arrest victims

Read 140 page market research report, "External Defibrillators Market Size, Share & Trends Analysis Report By Product (Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators), By Region, And Segment Forecasts, 2022 - 2030", by Grand View Research

According to the study published in Elsevier, Inc., the number of out-of-hospital cardiac arrests occurring in Paris and its suburbs almost doubled amid the pandemic, from March 16 to April 26, 2020. Such factors are expected to boost sales of external defibrillators. In addition, the International Liaison Committee on Cardiopulmonary Resuscitation (ILCOR) changed the resuscitation guidelines. The new rules suggested improving defibrillation delivery by providing training to healthcare workers, which can reduce confusion as well as the delay in COVID-19 resuscitation efforts. The training would also ensure that healthcare providers are not exposed to additional risks and patients uffering from tachyarrhythmia arrests can be provided the best chance of survival.

Increasing prevalence of the cardiovascular disease is a major driver for market growth. According to the WHO, in 2019, 17.9 million deaths occurred due to cardiovascular disease, which was estimated around 32% globally. Moreover, more than 75% of deaths occurred in middle- & low-income countries. According to American Heart Association, 390,000 sudden cardiac arrests were reported in 2018. Out of these, 65% of deaths occurred in people aged 75 & above, 6% deaths in the age group of 25 to 54 years, and 29% in the age group of 55 to 74 years. Owing to these factors, the demand for external defibrillators is anticipated to increase over the forecast period.

Despite developments in prevention and treatment, sudden cardiac death remains a leading cause of mortality and is accountable for nearly half of all deaths from cardiovascular ailments. The increasing prevalence of SCA and its associated risk factors are expected to increase the demand for AEDs. SCA is one of the leading causes of death around the globe. Moreover, it is the major cause of natural deaths in the U.S., resulting in about 325,000 adult deaths in the country every year. SCA is also responsible for half of all heart ailment deaths.

Market Segmentation:

Grand View Research has segmented the global external defibrillators market on the basis of product, end-use, and region:

  • External Defibrillators Product Outlook (Revenue, USD Million, 2017 - 2030)
    • Manual External Defibrillators
    • Automated External Defibrillators
      • Semi-Automated ED
      • Fully Automated ED
    • Wearable Cardioverter Defibrillators
  • External Defibrillators End-use Outlook (Revenue, USD Million, 2017 - 2030)
    • Hospital
    • Pre Hospital
    • Public Access Market
    • Alternate Care Market
    • Home Healthcare
  • External Defibrillators Regional Outlook (Revenue, USD Million, 2017 - 2030)
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

List of Key Players of the External Defibrillators Market

  • Koninklijke Philips N.V.
  • Stryker
  • ZOLL Medical Corporation
  • Nihon Kohden Corporation
  • ProgettiSrl
  • Schiller AG
  • MS Westfalia GmbH
  • AMI Italia
  • Bexen Cardio
  • Silverline Meditech Pvt. Ltd.
  • Mediana Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics
  • CU Medical
  • BPL Medical Technologies
  • Corpuls

Check out more studies related medical devices for cardiac diseases, published by Grand View Research:

  • Defibrillator Market – The global defibrillators market was valued at USD 10.9 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2021 to 2028. Rising adherence of integrated technology, incidences of cardiac disorders, awareness regarding the importance of good cardiac health, and legislative reforms are the key growth drivers for this market.
  • Cardiovascular Devices Market – The global cardiovascular devices market was valued over 33 billion in 2015 and is projected to grow at a CAGR of 6.6% over the forecast period. The prevalence of chronic heart ailments and sedentary lifestyles has been steadily rising thus engendering a high incidence of cardiac diseases.
  • Congestive Heart Failure Treatment Devices Market – The Congestive Heart Failure (CHF) treatment devices market was valued at USD 15.6 billion in 2015 and is expected to witness a CAGR of 8.1% over the forecast period. The rising burden of Cardiovascular Diseases (CVDs) is one of the prime factors responsible for the lucrative growth of the CHF treatment devices market.

Browse through Grand View Research's coverage of the Global Medical Devices Industry.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.


Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Follow Us: LinkedIn | Twitter 


[ Back To's Homepage ]